{"gene":"GRM8","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1996,"finding":"mGluR8 is localized presynaptically in axon terminals of projection neurons of the main olfactory bulb (rhinencephalon), as demonstrated by loss of immunoreactivity in layer Ia of piriform cortex after lateral olfactory tract transection and electron microscopic visualization of immunoreactivity in axon terminals making asymmetric synapses.","method":"Immunohistochemistry, electron microscopy, and lesion/tract-transection experiment","journal":"Neuroscience letters","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct lesion experiment combined with electron microscopy providing subcellular resolution, localization tied to functional presynaptic identity","pmids":["8710211"],"is_preprint":false},{"year":1998,"finding":"mGluR8a and mGluR8b splice variants, which differ only in their C-terminal domains (last 16 amino acids replaced by 16 different amino acids via out-of-frame insertion), display identical pharmacological profiles when expressed heterologously, with rank order of potency DL-AP4 > L-SOP > glutamate and higher agonist potencies than mGluR7. In Xenopus oocytes co-expressed with Kir3.1/3.4, mGluR8 couples to GIRK currents, blocked by the group II/III antagonist CPPG.","method":"Reverse transcription-PCR, transient transfection in HEK293 cells with chimeric Gαqi9, Xenopus oocyte electrophysiology","journal":"The European journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — heterologous expression with pharmacological characterization and electrophysiology in two systems, multiple orthogonal methods","pmids":["9875342"],"is_preprint":false},{"year":2002,"finding":"The mGlu8 receptor Venus flytrap module (VFTM) closure is required for receptor activation. Antagonists ACPT-II and MAP4 prevent VFTM closure via ionic (Asp-309) and steric (Tyr-227) hindrance respectively; alanine substitution of these residues converts the antagonists into full agonists, demonstrating that VFTM closure is necessary for family 3 GPCR activation.","method":"Site-directed mutagenesis, molecular modeling, functional assay in heterologous expression system","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — active-site mutagenesis combined with functional assay and molecular modeling, multiple mutants tested with orthogonal compounds","pmids":["12151600"],"is_preprint":false},{"year":2002,"finding":"mGlu8 receptors function as presynaptic autoreceptors selectively on lateral perforant path (LPP) afferents to the dentate gyrus. L-AP4 and the selective mGlu8 agonist DCPG suppress LPP-evoked fEPSPs in wild-type but not in mGlu8 knockout hippocampal slices; medial perforant path fEPSPs were unaffected by mGlu8 deletion.","method":"Field EPSP recording in hippocampal slices from wild-type and mGlu8 knockout mice, pharmacological dissection","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout combined with pharmacology and electrophysiology in defined pathway, replicated across studies","pmids":["12213276"],"is_preprint":false},{"year":2002,"finding":"mGlu8 receptor-deficient mice show increased anxiety-related behavior in the elevated plus maze (increased open arm avoidance and risk assessment), indicating mGlu8 plays a role in modulating responses to novel stressful environments.","method":"Behavioral phenotyping of mGlu8 knockout mice generated by homologous recombination","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with defined behavioral phenotype, replicated in independent knockout line but single readout per study","pmids":["12213278","12213279"],"is_preprint":false},{"year":2002,"finding":"Selective activation of mGlu8 receptors by DCPG reduces excitatory synaptic transmission (fEPSPs evoked by optic tract stimulation) in the superficial superior colliculus, antagonized by LY341495 at concentrations selective for mGlu8, indicating mGlu8 modulates glutamate release in the retino-collicular pathway.","method":"Field EPSP recording in rat superior colliculus in vitro slice preparation with pharmacological antagonism","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro electrophysiology with selective antagonist control, single lab","pmids":["12213277"],"is_preprint":false},{"year":2003,"finding":"Systemic administration of the mGlu8 agonist (S)-3,4-DCPG induces c-Fos expression in stress-related brain regions (paraventricular hypothalamus, central amygdala, lateral parabrachial nucleus, locus coeruleus) in wild-type but not mGlu8 knockout mice; over 92% of c-Fos positive neurons in the central amygdala were GABAergic, indicating mGlu8 activation modulates inhibitory neuronal activity in stress circuits.","method":"c-Fos immunohistochemistry, pharmacological challenge in wild-type vs. mGlu8 knockout mice, GABAergic neuron co-localization","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout controls confirm on-target specificity, multiple orthogonal methods (IHC, cell-type markers), dose-response","pmids":["12907308"],"is_preprint":false},{"year":2003,"finding":"In a pilocarpine model of limbic epilepsy, mGluR8 function at lateral perforant path terminals is downregulated in rats with spontaneous recurrent seizures (SRS): maximal L-AP4- and PPG-mediated inhibition of fEPSPs is significantly reduced (50% to 26% for L-AP4), without change in EC50, indicating loss of mGluR8 receptor number/efficacy rather than affinity.","method":"Field EPSP recording in hippocampal slices, concentration-response curves, pharmacological antagonism","journal":"Synapse","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro electrophysiology with pharmacological dissection in disease model, single lab","pmids":["12539201"],"is_preprint":false},{"year":2005,"finding":"mGlu8 receptor activation via intra-PAG (periaqueductal gray) perfusion with (S)-3,4-DCPG increases extracellular glutamate and decreases GABA levels; these effects are blocked by the group III antagonist MSOP and by the PKA inhibitor H-89, implicating adenylate cyclase/PKA signaling downstream of mGlu8 in differential regulation of glutamate and GABA release at the PAG.","method":"In vivo microdialysis in rat PAG, pharmacological antagonism with MSOP, UBP1112, and PKA inhibitor H-89","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo microdialysis with multiple pharmacological controls, single lab","pmids":["16084932"],"is_preprint":false},{"year":2005,"finding":"mGlu8 receptor activation by (S)-3,4-DCPG in the lateral amygdala attenuates synaptic transmission from sensory afferents presynaptically (increased paired-pulse facilitation, no postsynaptic effect), and inhibits acquisition and expression of conditioned fear (fear-potentiated startle) in vivo; LTP by tetanic stimulation was also inhibited.","method":"In vivo fear-potentiated startle, patch-clamp recording in amygdala slices, paired-pulse protocol","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo behavioral and in vitro electrophysiology, presynaptic mechanism supported by paired-pulse data, single lab","pmids":["16188284"],"is_preprint":false},{"year":2005,"finding":"mGluR8 activation in rod photoreceptors (by L-AP4, L-SOP, or L-glutamate) decreases cytosolic Ca2+ influx via a pertussis toxin-sensitive Gi/o protein and via Gβγ subunit signaling; suramin (G protein uncoupler), pertussis toxin, and a Gβγ-inhibiting peptide all abolish this effect, while cholera toxin (Gs activator) has no effect, and the absence of Go and Gz proteins suggests Gi2 and/or transducin as the coupling G protein.","method":"Microspectrofluorimetry of cytosolic Ca2+ in isolated rod photoreceptors, pertussis toxin, cholera toxin, Gβγ-inhibiting peptide, suramin","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple pharmacological G protein dissection tools applied to defined primary cells, multiple orthogonal mechanistic probes","pmids":["15623786"],"is_preprint":false},{"year":2008,"finding":"Both mGluR4 and mGluR8 contribute to presynaptic inhibition of synaptic transmission at the lateral olfactory tract–piriform cortex synapse; the selective mGluR8 agonist DCPG (300 nM) suppresses transmission, and the mGluR4 positive allosteric modulator PHCCC potentiates L-AP4 inhibition at this synapse.","method":"Whole-cell patch-clamp recordings in piriform cortex pyramidal cells, selective agonists and allosteric modulators","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patch-clamp with selective pharmacology, single lab","pmids":["18625254"],"is_preprint":false},{"year":2011,"finding":"mGluR8 mediates presynaptic depression of excitatory transmission in the bed nucleus of the stria terminalis (BNST): DCPG effects are absent in mGluR8 KO slices, associated with increased paired-pulse facilitation and decreased spontaneous EPSC frequency; this mGluR8-mediated suppression is disrupted by α1 adrenergic receptor activation and by both acute and chronic restraint stress in vivo, as well as in α2A AR KO mice.","method":"Electrophysiology in BNST slices from wild-type and mGlu8 KO mice, mGluR8 immunohistochemistry, pharmacological dissection with α1/α2 AR modulators, in vivo stress paradigms","journal":"Neuropsychopharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout, immunohistochemistry, and multiple pharmacological and stress manipulations in single study, multiple orthogonal methods","pmids":["21451497"],"is_preprint":false},{"year":2011,"finding":"mGluR8 achieves nearly complete inhibition of glutamate release at hippocampal lateral perforant path synapses without affecting presynaptic Ca2+ entry, diffusion, or buffering; instead, it acts by decreasing the apparent Ca2+ affinity of the release sensor and reducing maximal release rate. This action is resistant to inhibitors of adenylate cyclase and may represent a direct effect on the release machinery.","method":"Presynaptic Ca2+ imaging, miniature EPSC recording, quantitative Ca2+ dependence modeling, pharmacological blockade of adenylate cyclase and G-protein pathways","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (Ca2+ imaging, mEPSC, quantitative modeling, pharmacological dissection), mechanistically novel finding in single rigorous study","pmids":["21903594"],"is_preprint":false},{"year":2013,"finding":"mGlu8 but not mGlu7 ablation reduces contextual fear; mGlu8 agonist DCPG decreases synaptic transmission but not LTP at thalamo-lateral amygdala synapses, and intra-amygdala DCPG selectively reduces expression of contextual fear but not cued fear acquisition or expression, establishing distinct roles for mGlu7 and mGlu8 in amygdala synaptic physiology and fear behavior.","method":"Electrophysiology (LTP and synaptic transmission) in amygdala slices from mGlu7 and mGlu8 KO mice, intra-amygdala microinjection with behavioral fear testing","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic knockouts, in vitro electrophysiology, and in vivo behavioral experiments with pathway-level specificity","pmids":["23664812"],"is_preprint":false},{"year":2016,"finding":"mGluR8 negatively modulates TRPA1 activity on cutaneous nociceptors: DCPG (mGluR8 agonist) reduces TRPA1-mediated Ca2+ mobilization (co-localization of TRPA1 and mGluR8 confirmed), reverses mustard-oil-induced mechanical hypersensitivity in vivo, and reduces nociceptor firing at the single-fiber level; PKA inhibitor RpCAMPS mimics the DCPG effect, implicating the cAMP/PKA pathway.","method":"Ca2+ imaging in dorsal root ganglion neurons, in vivo paw withdrawal threshold testing, single-fiber electrophysiology, PKA inhibition","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (Ca2+ imaging, single-fiber recording, behavioral) in single lab, co-localization and functional coupling shown","pmids":["27497709"],"is_preprint":false},{"year":2018,"finding":"The crystal structure of the human mGlu8 amino terminal domain (ATD) bound to L-AP4 and to L-glutamate was solved, revealing that L-glutamate binds differently in mGlu8 compared to mGlu1, and that both the electronic and steric properties of the distal phosphate of L-AP4 account for its group III selectivity.","method":"X-ray crystallography of recombinant human mGlu8 ATD","journal":"Bioorganic & medicinal chemistry letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional interpretation, single lab but direct structural determination","pmids":["29402739"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of recombinant human mGlu8 ATD bound to (S)-DCPG was solved; the structure shows the largest lobe opening angle among known agonist-bound mGlu ATD structures, and the DCPG binding conformation differs substantially from homology-model predictions, rationalizing (S)-DCPG's high mGlu8 subtype selectivity.","method":"X-ray crystallography, homology modeling of other mGlu subtypes","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct crystal structure with comparative structural analysis providing mechanistic basis for selectivity, single lab","pmids":["30365309"],"is_preprint":false},{"year":2018,"finding":"GRM8 transcriptional activation in squamous cell lung cancer promotes tumor cell survival by inhibiting the cAMP pathway and activating the MAPK pathway; the SNV A112G identified in GRM8 activates downstream signaling and induces cell proliferation, reversed by cAMP stimulator and MEK inhibitor.","method":"CRISPR-Cas9 genome editing in patient-derived xenograft cells, cAMP and MAPK pathway assays, pharmacological rescue","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional genetic validation with CRISPR in primary tumor cells plus pharmacological pathway dissection, single lab","pmids":["30391781"],"is_preprint":false},{"year":2018,"finding":"mGluR8 downregulation in human neuroblastoma (SH-SY5Y) cells increases proliferation and chemoresistance (to staurosporine, doxorubicin, irinotecan, cisplatin) with decreased caspase, calpain, GSK-3β, Akt, and JNK activity; conversely, mGluR8 overexpression in glioma cells (U87-MG, LN18) decreases proliferation and increases apoptosis and chemosensitivity, identifying a tumor suppressor role.","method":"RNAi knockdown and cDNA overexpression, cell proliferation assays, caspase/calpain activity assays, kinase activity measurement","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional genetic manipulation (knockdown and overexpression) in multiple cell lines with multiple readouts, single lab","pmids":["29885518"],"is_preprint":false},{"year":2010,"finding":"Selective activation of mGluR8 by DCPG reversibly reduces Off-light responses of retinal ganglion cells in wild-type but not mGluR8-deficient retinas by suppressing both excitatory and inhibitory synaptic conductances, indicating mGluR8 reduces glutamate release from bipolar cell terminals and possibly inhibitory transmitter release from amacrine cells.","method":"Extracellular and whole-cell light-evoked recording in wild-type and mGluR8 KO mouse retina","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout control, whole-cell conductance measurement, multiple cell types assessed","pmids":["20096339"],"is_preprint":false},{"year":2024,"finding":"mGlu8 receptor activation (DCPG) in the dentate gyrus inhibits LTP in normal rats but enhances impaired LTP in VPA-exposed (autism model) rats at the perforant path–dentate gyrus synapse; intra-DG DCPG also reverses reduced social novelty preference in VPA-exposed rats, suggesting mGlu8 dysfunction contributes to impaired synaptic plasticity in this ASD model.","method":"In vivo hippocampal field recording with high-frequency stimulation, intra-DG microinjection, social behavior testing in VPA rat model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo electrophysiology and behavioral assay with intra-site pharmacology, single lab","pmids":["38849397"],"is_preprint":false},{"year":2024,"finding":"In the thalamic reticular nucleus (TRN), mGlu8 (grm8) mRNA is expressed in parvalbumin-positive cells of both TRN core and shell matrices and in cortical layers involved in corticothalamic signaling. Constitutive parvalbumin-specific mGlu8 knockout increases spontaneous excitatory drive onto dorsal thalamus relay cells and impairs sensorimotor gating (paired-pulse inhibition); TRN-conditional AAV-mediated grm8 knockdown produces hyperlocomotion and anxiolytic effects in repeated open field testing.","method":"Fluorescent in situ hybridization, conditional (AAV-CRE) and cell-type-specific constitutive knockout, whole-cell patch-clamp, paired-pulse inhibition, open field behavioral testing","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic strategies (constitutive cell-type KO + conditional viral KO), electrophysiology and behavior, cell-type resolution with FISH","pmids":["38918065"],"is_preprint":false},{"year":2012,"finding":"DCPG at submicromolar concentrations selectively inhibits excitatory transmission in the lateral perforant path (LPP) via mGlu8; at concentrations >1 μM, DCPG produces additional non-selective effects in both LPP and medial perforant path (MPP) that are absent in mGlu8 KO but mediated primarily by mGlu2, as shown in mGlu2, mGlu4, and mGlu7 KO mice and an mGlu2-deficient rat substrain.","method":"Field EPSP recording in hippocampal slices from multiple receptor-specific knockout mice and a naturally mGlu2-deficient rat substrain","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic knockout models used to dissect receptor contributions, defines concentration-selectivity window for mGlu8","pmids":["23220400"],"is_preprint":false}],"current_model":"GRM8 encodes a presynaptically localized group III metabotropic glutamate receptor that, upon agonist binding to its Venus flytrap module (VFTM closure required for activation), couples via pertussis-toxin-sensitive Gi/o proteins (Gβγ subunit signaling) to inhibit neurotransmitter release—not primarily by reducing Ca2+ entry but by decreasing the apparent Ca2+ affinity of the vesicle release sensor—at multiple CNS synapses including lateral perforant path–dentate gyrus, lateral olfactory tract–piriform cortex, retino-collicular, amygdalar, BNST, and thalamocortical synapses; in the TRN, mGlu8 in parvalbumin neurons restrains excitatory drive onto thalamic relay cells and supports sensorimotor gating, while peripherally it negatively modulates TRPA1 via the cAMP/PKA pathway; in cancer cells it acts as a tumor suppressor by inhibiting the cAMP pathway and modulating MAPK signaling, and its loss or gain-of-function produces anxiety, contextual fear, and sensorimotor gating phenotypes in rodents."},"narrative":{"mechanistic_narrative":"GRM8 encodes mGlu8, a presynaptically localized group III metabotropic glutamate receptor that acts as an inhibitory autoreceptor restraining excitatory neurotransmitter release at defined CNS synapses [PMID:8710211, PMID:12213276]. Agonist binding requires closure of the receptor's Venus flytrap module: antagonists block activation by preventing lobe closure through ionic and steric hindrance, and mutating those contact residues converts antagonists into full agonists, establishing VFTM closure as the gating step for this family 3 GPCR [PMID:12151600]; crystal structures of the human amino-terminal domain bound to L-AP4, L-glutamate, and the selective agonist DCPG rationalize group III and mGlu8-subtype selectivity [PMID:29402739, PMID:30365309]. The receptor couples through pertussis-toxin-sensitive Gi/o proteins via Gβγ signaling, and in heterologous systems activates GIRK currents [PMID:9875342, PMID:15623786]. At lateral perforant path–dentate gyrus terminals, mGlu8 produces near-complete inhibition of glutamate release without reducing presynaptic Ca2+ entry, instead lowering the apparent Ca2+ affinity of the release sensor and the maximal release rate in a manner resistant to adenylate cyclase inhibition—indicating a direct action on the release machinery [PMID:21903594]. This presynaptic depression is selective and broadly distributed, demonstrated by knockout-confirmed, agonist-dependent suppression of transmission at lateral olfactory tract–piriform cortex, retino-collicular, retinal bipolar, amygdalar, and BNST synapses [PMID:12213276, PMID:12213277, PMID:18625254, PMID:21451497, PMID:20096339, PMID:23220400]. Functionally, mGlu8 modulates stress and fear circuitry: agonist activation engages GABAergic neurons in stress-related regions, attenuates amygdalar sensory transmission to inhibit conditioned and contextual fear, and its loss heightens anxiety, while in the thalamic reticular nucleus parvalbumin-neuron mGlu8 restrains excitatory drive onto relay cells and supports sensorimotor gating [PMID:12213278, PMID:12213279, PMID:12907308, PMID:16188284, PMID:23664812, PMID:38918065]. Beyond the CNS, mGlu8 negatively modulates TRPA1 in cutaneous nociceptors via the cAMP/PKA pathway [PMID:27497709], and in cancer cells it acts through cAMP and MAPK signaling with both tumor-suppressor and, via a gain-of-function variant, tumor-promoting effects [PMID:30391781, PMID:29885518].","teleology":[{"year":1996,"claim":"Established where mGlu8 acts by showing it resides in presynaptic axon terminals of projection neurons, defining it as a candidate release-modulating autoreceptor.","evidence":"Immunohistochemistry and electron microscopy combined with lateral olfactory tract transection in rhinencephalon","pmids":["8710211"],"confidence":"High","gaps":["Did not establish the downstream signaling or release-modulating function","No physiological readout of receptor activity"]},{"year":1998,"claim":"Defined the receptor's pharmacology and effector coupling, showing two C-terminal splice variants with identical agonist profiles and coupling to GIRK channels.","evidence":"RT-PCR, heterologous expression in HEK293 with chimeric Gαqi9, and Xenopus oocyte electrophysiology with Kir3.1/3.4","pmids":["9875342"],"confidence":"High","gaps":["Functional significance of C-terminal splice variation unresolved","Native G-protein coupling not identified in this heterologous system"]},{"year":2002,"claim":"Defined the molecular gating mechanism by showing Venus flytrap closure is required for activation, with specific residues controlling antagonist-versus-agonist behavior.","evidence":"Site-directed mutagenesis, molecular modeling, and functional assay in heterologous expression","pmids":["12151600"],"confidence":"High","gaps":["Did not resolve how VFTM closure propagates to the transmembrane domain","No structural confirmation at the time"]},{"year":2002,"claim":"Demonstrated native autoreceptor function with pathway selectivity, showing mGlu8 suppresses transmission specifically at lateral perforant path and retino-collicular synapses.","evidence":"Field EPSP recording in wild-type vs mGlu8 knockout slices with selective agonist DCPG and antagonist LY341495","pmids":["12213276","12213277"],"confidence":"High","gaps":["Mechanism of release suppression not yet defined","Pathway selectivity basis unknown"]},{"year":2002,"claim":"Linked mGlu8 loss to anxiety behavior, connecting the receptor to emotional regulation in vivo.","evidence":"Behavioral phenotyping of independent mGlu8 knockout lines in the elevated plus maze","pmids":["12213278","12213279"],"confidence":"Medium","gaps":["Single behavioral readout per study","Circuit responsible for the phenotype not identified"]},{"year":2003,"claim":"Connected receptor activation to stress circuitry and showed engagement of GABAergic neurons, and that mGlu8 function is downregulated in epilepsy.","evidence":"c-Fos immunohistochemistry in wild-type vs knockout mice with GABAergic markers; concentration-response fEPSP recordings in a pilocarpine epilepsy model","pmids":["12907308","12539201"],"confidence":"Medium","gaps":["Causal contribution of GABAergic engagement to behavior not established","Mechanism of disease-associated downregulation unknown"]},{"year":2005,"claim":"Resolved the G-protein effector mechanism in primary cells and showed differential transmitter regulation through a cAMP/PKA arm.","evidence":"Microspectrofluorimetry of Ca2+ in rod photoreceptors with PTX, CTX, Gβγ-inhibiting peptide and suramin; in vivo PAG microdialysis with PKA inhibitor H-89; amygdala patch-clamp with paired-pulse analysis","pmids":["15623786","16084932","16188284"],"confidence":"High","gaps":["Whether cAMP/PKA versus Ca2+-affinity mechanisms operate synapse-specifically not reconciled","Identity of native coupling Gi isoform inferred, not proven"]},{"year":2011,"claim":"Defined the core presynaptic mechanism: near-complete release inhibition by lowering Ca2+ sensitivity of the release sensor rather than reducing Ca2+ entry, independent of adenylate cyclase.","evidence":"Presynaptic Ca2+ imaging, mEPSC recording, quantitative Ca2+-dependence modeling and pharmacological dissection at hippocampal LPP synapses","pmids":["21903594","21451497"],"confidence":"High","gaps":["Molecular target on the release machinery not identified","Reconciliation with cAMP/PKA-dependent effects elsewhere unresolved"]},{"year":2013,"claim":"Distinguished mGlu8 from mGlu7 in amygdala physiology and fear, assigning mGlu8 a selective role in contextual fear expression.","evidence":"Electrophysiology and intra-amygdala microinjection with fear behavior in mGlu7 and mGlu8 knockout mice","pmids":["23664812"],"confidence":"High","gaps":["Synaptic basis of contextual-versus-cued specificity not defined"]},{"year":2016,"claim":"Extended mGlu8 function to peripheral nociception, showing negative modulation of TRPA1 via cAMP/PKA.","evidence":"DRG Ca2+ imaging, single-fiber recording, behavioral paw-withdrawal testing, and PKA inhibition","pmids":["27497709"],"confidence":"Medium","gaps":["Single lab","Direct molecular link between PKA and TRPA1 not established"]},{"year":2018,"claim":"Provided structural basis for ligand selectivity and revealed non-neuronal cancer roles through cAMP and MAPK signaling.","evidence":"X-ray crystallography of human ATD bound to L-AP4, L-glutamate, and DCPG; CRISPR and RNAi/overexpression in lung cancer, neuroblastoma and glioma cells with pathway rescue","pmids":["29402739","30365309","30391781","29885518"],"confidence":"Medium","gaps":["Opposing tumor-suppressor and tumor-promoter findings not mechanistically reconciled","Cancer signaling shown in single labs without in vivo confirmation"]},{"year":2024,"claim":"Assigned mGlu8 a cell-type-specific role in thalamic circuit gating and in disease-model plasticity, linking it to sensorimotor gating and ASD-relevant deficits.","evidence":"FISH, parvalbumin-specific and AAV-conditional knockout with patch-clamp, paired-pulse inhibition and open-field behavior in TRN; in vivo DG field recording and social behavior in the VPA rat model","pmids":["38918065","38849397"],"confidence":"High","gaps":["Circuit mechanism translating TRN mGlu8 loss to gating deficits incomplete","Whether VPA-model effects generalize to other ASD models unknown"]},{"year":null,"claim":"The molecular target on the vesicle release machinery through which mGlu8 lowers Ca2+-sensor affinity, and how this adenylate-cyclase-independent action coexists with cAMP/PKA-dependent effects in other tissues, remain unidentified.","evidence":"","pmids":[],"confidence":"High","gaps":["No defined effector at the release sensor","Synapse- and tissue-specific switching between effector arms unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,1]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,13]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O00222","full_name":"Metabotropic glutamate receptor 8","aliases":[],"length_aa":908,"mass_kda":101.7,"function":"G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/O00222/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GRM8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GRM8","total_profiled":1310},"omim":[{"mim_id":"604510","title":"HYALURONOGLUCOSAMINIDASE 4; HYAL4","url":"https://www.omim.org/entry/604510"},{"mim_id":"604473","title":"GLUTAMATE RECEPTOR, METABOTROPIC, 1; GRM1","url":"https://www.omim.org/entry/604473"},{"mim_id":"603590","title":"ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE1","url":"https://www.omim.org/entry/603590"},{"mim_id":"601116","title":"GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8","url":"https://www.omim.org/entry/601116"},{"mim_id":"601115","title":"GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3","url":"https://www.omim.org/entry/601115"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"choroid plexus","ntpm":20.4}],"url":"https://www.proteinatlas.org/search/GRM8"},"hgnc":{"alias_symbol":["GLUR8","GPRC1H","mGlu8","MGLUR8"],"prev_symbol":[]},"alphafold":{"accession":"O00222","domains":[{"cath_id":"3.40.50.2300","chopping":"38-124_145-172_339-373_392-457","consensus_level":"high","plddt":90.8235,"start":38,"end":457},{"cath_id":"3.40.50.2300","chopping":"200-335_470-502","consensus_level":"medium","plddt":91.846,"start":200,"end":502},{"cath_id":"-","chopping":"525-572","consensus_level":"medium","plddt":89.7304,"start":525,"end":572},{"cath_id":"1.20.1070","chopping":"583-685_750-849","consensus_level":"high","plddt":88.687,"start":583,"end":849}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00222","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00222-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00222-F1-predicted_aligned_error_v6.png","plddt_mean":84.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GRM8","jax_strain_url":"https://www.jax.org/strain/search?query=GRM8"},"sequence":{"accession":"O00222","fasta_url":"https://rest.uniprot.org/uniprotkb/O00222.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00222/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00222"}},"corpus_meta":[{"pmid":"16324694","id":"PMC_16324694","title":"Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.","date":"2005","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16324694","citation_count":116,"is_preprint":false},{"pmid":"9875342","id":"PMC_9875342","title":"Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8.","date":"1998","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9875342","citation_count":108,"is_preprint":false},{"pmid":"12151600","id":"PMC_12151600","title":"Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12151600","citation_count":85,"is_preprint":false},{"pmid":"12213279","id":"PMC_12213279","title":"Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor.","date":"2002","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12213279","citation_count":82,"is_preprint":false},{"pmid":"16045496","id":"PMC_16045496","title":"Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8.","date":"2005","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16045496","citation_count":77,"is_preprint":false},{"pmid":"12213278","id":"PMC_12213278","title":"Performance deficits of mGluR8 knockout mice in learning tasks: the effects of null mutation and the background genotype.","date":"2002","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12213278","citation_count":58,"is_preprint":false},{"pmid":"18618593","id":"PMC_18618593","title":"Association of single nucleotide polymorphisms in a glutamate receptor gene (GRM8) with theta power of event-related oscillations and alcohol dependence.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18618593","citation_count":57,"is_preprint":false},{"pmid":"15589052","id":"PMC_15589052","title":"Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions.","date":"2005","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/15589052","citation_count":56,"is_preprint":false},{"pmid":"17113112","id":"PMC_17113112","title":"Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.","date":"2006","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17113112","citation_count":53,"is_preprint":false},{"pmid":"8710211","id":"PMC_8710211","title":"Presynaptic localization of a metabotropic glutamate receptor, mGluR8, in the rhinencephalic areas: a light and electron microscope study in the rat.","date":"1996","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/8710211","citation_count":51,"is_preprint":false},{"pmid":"17434465","id":"PMC_17434465","title":"Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17434465","citation_count":49,"is_preprint":false},{"pmid":"17955477","id":"PMC_17955477","title":"The association analysis of RELN and GRM8 genes with autistic spectrum disorder in Chinese Han population.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17955477","citation_count":48,"is_preprint":false},{"pmid":"12213276","id":"PMC_12213276","title":"Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors.","date":"2002","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12213276","citation_count":42,"is_preprint":false},{"pmid":"15211621","id":"PMC_15211621","title":"Positive associations of polymorphisms in the metabotropic glutamate receptor type 8 gene (GRM8) with schizophrenia.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15211621","citation_count":42,"is_preprint":false},{"pmid":"19740090","id":"PMC_19740090","title":"The effect of mGlu8 deficiency in animal models of psychiatric diseases.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19740090","citation_count":42,"is_preprint":false},{"pmid":"30391781","id":"PMC_30391781","title":"Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30391781","citation_count":36,"is_preprint":false},{"pmid":"26655190","id":"PMC_26655190","title":"Significant association of GRM7 and GRM8 genes with schizophrenia and major depressive disorder in the Han Chinese population.","date":"2015","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26655190","citation_count":35,"is_preprint":false},{"pmid":"8824806","id":"PMC_8824806","title":"Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8824806","citation_count":35,"is_preprint":false},{"pmid":"16084932","id":"PMC_16084932","title":"Differential roles of mGlu8 receptors in the regulation of glutamate and gamma-aminobutyric acid release at periaqueductal grey level.","date":"2005","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16084932","citation_count":34,"is_preprint":false},{"pmid":"16188284","id":"PMC_16188284","title":"Effects of the mGluR8 agonist (S)-3,4-DCPG in the lateral amygdala on acquisition/expression of fear-potentiated startle, synaptic transmission, and plasticity.","date":"2005","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16188284","citation_count":33,"is_preprint":false},{"pmid":"9299241","id":"PMC_9299241","title":"The human metabotropic glutamate receptor 8 (GRM8) gene: a disproportionately large gene located at 7q31.3-q32.1.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9299241","citation_count":32,"is_preprint":false},{"pmid":"23664812","id":"PMC_23664812","title":"Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology.","date":"2013","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23664812","citation_count":32,"is_preprint":false},{"pmid":"12907308","id":"PMC_12907308","title":"Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout mice.","date":"2003","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12907308","citation_count":32,"is_preprint":false},{"pmid":"30072879","id":"PMC_30072879","title":"Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice.","date":"2018","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30072879","citation_count":27,"is_preprint":false},{"pmid":"12539201","id":"PMC_12539201","title":"Down-regulation of mGluR8 in pilocarpine epileptic rats.","date":"2003","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12539201","citation_count":26,"is_preprint":false},{"pmid":"28322866","id":"PMC_28322866","title":"Decreased anxiety, voluntary ethanol intake and ethanol-induced CPP acquisition following activation of the metabotropic glutamate receptor 8 \"mGluR8\".","date":"2017","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/28322866","citation_count":25,"is_preprint":false},{"pmid":"15215559","id":"PMC_15215559","title":"Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist.","date":"2004","source":"Polish journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15215559","citation_count":24,"is_preprint":false},{"pmid":"21451497","id":"PMC_21451497","title":"mGluR8 modulates excitatory transmission in the bed nucleus of the stria terminalis in a stress-dependent manner.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21451497","citation_count":23,"is_preprint":false},{"pmid":"12213277","id":"PMC_12213277","title":"Reduction of excitatory transmission in the retino-collicular pathway via selective activation of mGlu8 receptors by DCPG.","date":"2002","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12213277","citation_count":22,"is_preprint":false},{"pmid":"16382208","id":"PMC_16382208","title":"Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats.","date":"2005","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/16382208","citation_count":22,"is_preprint":false},{"pmid":"29885518","id":"PMC_29885518","title":"An endogenous and ectopic expression of metabotropic glutamate receptor 8 (mGluR8) inhibits proliferation and increases chemosensitivity of human neuroblastoma and glioma cells.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/29885518","citation_count":20,"is_preprint":false},{"pmid":"28224041","id":"PMC_28224041","title":"A 7q31.33q32.1 microdeletion including LRRC4 and GRM8 is associated with severe intellectual disability and characteristics of autism.","date":"2017","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/28224041","citation_count":19,"is_preprint":false},{"pmid":"18625254","id":"PMC_18625254","title":"Metabotropic glutamate receptors mGluR4 and mGluR8 regulate transmission in the lateral olfactory tract-piriform cortex synapse.","date":"2008","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18625254","citation_count":19,"is_preprint":false},{"pmid":"15623786","id":"PMC_15623786","title":"Interaction between mGluR8 and calcium channels in photoreceptors is sensitive to pertussis toxin and occurs via G protein betagamma subunit signaling.","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15623786","citation_count":18,"is_preprint":false},{"pmid":"23220400","id":"PMC_23220400","title":"Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus.","date":"2012","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23220400","citation_count":16,"is_preprint":false},{"pmid":"10690750","id":"PMC_10690750","title":"No association found between polymorphisms in genes encoding mGluR7 and mGluR8 and idiopathic generalised epilepsy in a case control study.","date":"2000","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/10690750","citation_count":16,"is_preprint":false},{"pmid":"11912074","id":"PMC_11912074","title":"No association between metabotropic glutamate receptors 7 and 8 (mGlur7 and mGlur8) gene polymorphisms and withdrawal seizures and delirium tremens in alcohol-dependent individuals.","date":"2002","source":"Alcohol and alcoholism (Oxford, Oxfordshire)","url":"https://pubmed.ncbi.nlm.nih.gov/11912074","citation_count":15,"is_preprint":false},{"pmid":"24392270","id":"PMC_24392270","title":"The role of rs2237781 within GRM8 in eating behavior.","date":"2013","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/24392270","citation_count":15,"is_preprint":false},{"pmid":"23948069","id":"PMC_23948069","title":"Related functions of mGlu4 and mGlu8.","date":"2013","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23948069","citation_count":14,"is_preprint":false},{"pmid":"17430409","id":"PMC_17430409","title":"Anticonvulsive effect of a selective mGluR8 agonist (S)-3,4-dicarboxyphenylglycine (S-3,4-DCPG) in the mouse pilocarpine model of status epilepticus.","date":"2007","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/17430409","citation_count":11,"is_preprint":false},{"pmid":"25978827","id":"PMC_25978827","title":"Further Analyses of Genetic Association Between GRM8 and Alcohol Dependence Symptoms Among Young Adults.","date":"2015","source":"Journal of studies on alcohol and drugs","url":"https://pubmed.ncbi.nlm.nih.gov/25978827","citation_count":11,"is_preprint":false},{"pmid":"25588301","id":"PMC_25588301","title":"Association analysis of the GRM8 gene with schizophrenia in the Uygur Chinese population.","date":"2014","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/25588301","citation_count":10,"is_preprint":false},{"pmid":"38849397","id":"PMC_38849397","title":"Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38849397","citation_count":10,"is_preprint":false},{"pmid":"29402739","id":"PMC_29402739","title":"Determination of L-AP4-bound human mGlu8 receptor amino terminal domain structure and the molecular basis for L-AP4's group III mGlu receptor functional potency and selectivity.","date":"2018","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/29402739","citation_count":10,"is_preprint":false},{"pmid":"30288643","id":"PMC_30288643","title":"TCF4 and GRM8 gene polymorphisms and risk of schizophrenia in an Iranian population: a case-control study.","date":"2018","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30288643","citation_count":8,"is_preprint":false},{"pmid":"30365309","id":"PMC_30365309","title":"Structural Basis for ( S)-3,4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu8 Receptor.","date":"2018","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30365309","citation_count":8,"is_preprint":false},{"pmid":"33612106","id":"PMC_33612106","title":"The effect of the mGlu8 receptor agonist, (S)-3,4-DCPG on acquisition and expression of morphine-induced conditioned place preference in male rats.","date":"2021","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/33612106","citation_count":6,"is_preprint":false},{"pmid":"21903594","id":"PMC_21903594","title":"Depression of release by mGluR8 alters Ca2+ dependence of release machinery.","date":"2011","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/21903594","citation_count":6,"is_preprint":false},{"pmid":"20096339","id":"PMC_20096339","title":"Selective activation of mGluR8 receptors modulates retinal ganglion cell light responses.","date":"2010","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20096339","citation_count":6,"is_preprint":false},{"pmid":"27497709","id":"PMC_27497709","title":"Group III mGluR8 negatively modulates TRPA1.","date":"2016","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27497709","citation_count":4,"is_preprint":false},{"pmid":"29753314","id":"PMC_29753314","title":"Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State.","date":"2018","source":"Basic & clinical pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29753314","citation_count":4,"is_preprint":false},{"pmid":"38644811","id":"PMC_38644811","title":"Rare CRHR2 and GRM8 variants identified as candidate factors associated with eating disorders in Japanese patients by whole exome sequencing.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38644811","citation_count":2,"is_preprint":false},{"pmid":"27914294","id":"PMC_27914294","title":"Selective agonism of mGlu8 receptors by (S)-3,4-dicarboxyphenylglycine does not affect sleep stages in the rat.","date":"2016","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/27914294","citation_count":2,"is_preprint":false},{"pmid":"38653345","id":"PMC_38653345","title":"S-3,4-DCPG, a potent orthosteric agonist for the mGlu8 receptor, facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats.","date":"2024","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/38653345","citation_count":1,"is_preprint":false},{"pmid":"40133378","id":"PMC_40133378","title":"Developmental differentiation of mouse inner ear neuron subpopulations resolved with a peripherin-promoter reporter within the Grm8 locus.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40133378","citation_count":1,"is_preprint":false},{"pmid":"41011178","id":"PMC_41011178","title":"Isoliquiritigenin as a Neuronal Radiation Mitigant: Mitigating Radiation-Induced Anhedonia Tendency Targeting Grik3/Grm8/Grin3a via Integrated Proteomics and AI-Driven Discovery.","date":"2025","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/41011178","citation_count":1,"is_preprint":false},{"pmid":"23034312","id":"PMC_23034312","title":"Effects of (RS)-3,4-DCPG, a mixed AMPA antagonist/mGluR8 agonist, on aggressive behavior in mice.","date":"2009","source":"Revista de psiquiatria y salud mental","url":"https://pubmed.ncbi.nlm.nih.gov/23034312","citation_count":1,"is_preprint":false},{"pmid":"38918065","id":"PMC_38918065","title":"Thalamocortical mGlu8 Modulates Dorsal Thalamus Excitatory Transmission and Sensorimotor Activity.","date":"2024","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38918065","citation_count":0,"is_preprint":false},{"pmid":"40010564","id":"PMC_40010564","title":"Red nucleus mGluR4 and mGluR8 inhibit nociception and the development of neuropathic pain by restraining the expressions of TNF-α and IL-1β.","date":"2025","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40010564","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":31963,"output_tokens":6292,"usd":0.095134,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15122,"output_tokens":3960,"usd":0.087305,"stage2_stop_reason":"end_turn"},"total_usd":0.182439,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"mGluR8 is localized presynaptically in axon terminals of projection neurons of the main olfactory bulb (rhinencephalon), as demonstrated by loss of immunoreactivity in layer Ia of piriform cortex after lateral olfactory tract transection and electron microscopic visualization of immunoreactivity in axon terminals making asymmetric synapses.\",\n      \"method\": \"Immunohistochemistry, electron microscopy, and lesion/tract-transection experiment\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct lesion experiment combined with electron microscopy providing subcellular resolution, localization tied to functional presynaptic identity\",\n      \"pmids\": [\"8710211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"mGluR8a and mGluR8b splice variants, which differ only in their C-terminal domains (last 16 amino acids replaced by 16 different amino acids via out-of-frame insertion), display identical pharmacological profiles when expressed heterologously, with rank order of potency DL-AP4 > L-SOP > glutamate and higher agonist potencies than mGluR7. In Xenopus oocytes co-expressed with Kir3.1/3.4, mGluR8 couples to GIRK currents, blocked by the group II/III antagonist CPPG.\",\n      \"method\": \"Reverse transcription-PCR, transient transfection in HEK293 cells with chimeric Gαqi9, Xenopus oocyte electrophysiology\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — heterologous expression with pharmacological characterization and electrophysiology in two systems, multiple orthogonal methods\",\n      \"pmids\": [\"9875342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The mGlu8 receptor Venus flytrap module (VFTM) closure is required for receptor activation. Antagonists ACPT-II and MAP4 prevent VFTM closure via ionic (Asp-309) and steric (Tyr-227) hindrance respectively; alanine substitution of these residues converts the antagonists into full agonists, demonstrating that VFTM closure is necessary for family 3 GPCR activation.\",\n      \"method\": \"Site-directed mutagenesis, molecular modeling, functional assay in heterologous expression system\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — active-site mutagenesis combined with functional assay and molecular modeling, multiple mutants tested with orthogonal compounds\",\n      \"pmids\": [\"12151600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"mGlu8 receptors function as presynaptic autoreceptors selectively on lateral perforant path (LPP) afferents to the dentate gyrus. L-AP4 and the selective mGlu8 agonist DCPG suppress LPP-evoked fEPSPs in wild-type but not in mGlu8 knockout hippocampal slices; medial perforant path fEPSPs were unaffected by mGlu8 deletion.\",\n      \"method\": \"Field EPSP recording in hippocampal slices from wild-type and mGlu8 knockout mice, pharmacological dissection\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout combined with pharmacology and electrophysiology in defined pathway, replicated across studies\",\n      \"pmids\": [\"12213276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"mGlu8 receptor-deficient mice show increased anxiety-related behavior in the elevated plus maze (increased open arm avoidance and risk assessment), indicating mGlu8 plays a role in modulating responses to novel stressful environments.\",\n      \"method\": \"Behavioral phenotyping of mGlu8 knockout mice generated by homologous recombination\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with defined behavioral phenotype, replicated in independent knockout line but single readout per study\",\n      \"pmids\": [\"12213278\", \"12213279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Selective activation of mGlu8 receptors by DCPG reduces excitatory synaptic transmission (fEPSPs evoked by optic tract stimulation) in the superficial superior colliculus, antagonized by LY341495 at concentrations selective for mGlu8, indicating mGlu8 modulates glutamate release in the retino-collicular pathway.\",\n      \"method\": \"Field EPSP recording in rat superior colliculus in vitro slice preparation with pharmacological antagonism\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro electrophysiology with selective antagonist control, single lab\",\n      \"pmids\": [\"12213277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Systemic administration of the mGlu8 agonist (S)-3,4-DCPG induces c-Fos expression in stress-related brain regions (paraventricular hypothalamus, central amygdala, lateral parabrachial nucleus, locus coeruleus) in wild-type but not mGlu8 knockout mice; over 92% of c-Fos positive neurons in the central amygdala were GABAergic, indicating mGlu8 activation modulates inhibitory neuronal activity in stress circuits.\",\n      \"method\": \"c-Fos immunohistochemistry, pharmacological challenge in wild-type vs. mGlu8 knockout mice, GABAergic neuron co-localization\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout controls confirm on-target specificity, multiple orthogonal methods (IHC, cell-type markers), dose-response\",\n      \"pmids\": [\"12907308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In a pilocarpine model of limbic epilepsy, mGluR8 function at lateral perforant path terminals is downregulated in rats with spontaneous recurrent seizures (SRS): maximal L-AP4- and PPG-mediated inhibition of fEPSPs is significantly reduced (50% to 26% for L-AP4), without change in EC50, indicating loss of mGluR8 receptor number/efficacy rather than affinity.\",\n      \"method\": \"Field EPSP recording in hippocampal slices, concentration-response curves, pharmacological antagonism\",\n      \"journal\": \"Synapse\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro electrophysiology with pharmacological dissection in disease model, single lab\",\n      \"pmids\": [\"12539201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"mGlu8 receptor activation via intra-PAG (periaqueductal gray) perfusion with (S)-3,4-DCPG increases extracellular glutamate and decreases GABA levels; these effects are blocked by the group III antagonist MSOP and by the PKA inhibitor H-89, implicating adenylate cyclase/PKA signaling downstream of mGlu8 in differential regulation of glutamate and GABA release at the PAG.\",\n      \"method\": \"In vivo microdialysis in rat PAG, pharmacological antagonism with MSOP, UBP1112, and PKA inhibitor H-89\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo microdialysis with multiple pharmacological controls, single lab\",\n      \"pmids\": [\"16084932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"mGlu8 receptor activation by (S)-3,4-DCPG in the lateral amygdala attenuates synaptic transmission from sensory afferents presynaptically (increased paired-pulse facilitation, no postsynaptic effect), and inhibits acquisition and expression of conditioned fear (fear-potentiated startle) in vivo; LTP by tetanic stimulation was also inhibited.\",\n      \"method\": \"In vivo fear-potentiated startle, patch-clamp recording in amygdala slices, paired-pulse protocol\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo behavioral and in vitro electrophysiology, presynaptic mechanism supported by paired-pulse data, single lab\",\n      \"pmids\": [\"16188284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"mGluR8 activation in rod photoreceptors (by L-AP4, L-SOP, or L-glutamate) decreases cytosolic Ca2+ influx via a pertussis toxin-sensitive Gi/o protein and via Gβγ subunit signaling; suramin (G protein uncoupler), pertussis toxin, and a Gβγ-inhibiting peptide all abolish this effect, while cholera toxin (Gs activator) has no effect, and the absence of Go and Gz proteins suggests Gi2 and/or transducin as the coupling G protein.\",\n      \"method\": \"Microspectrofluorimetry of cytosolic Ca2+ in isolated rod photoreceptors, pertussis toxin, cholera toxin, Gβγ-inhibiting peptide, suramin\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple pharmacological G protein dissection tools applied to defined primary cells, multiple orthogonal mechanistic probes\",\n      \"pmids\": [\"15623786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Both mGluR4 and mGluR8 contribute to presynaptic inhibition of synaptic transmission at the lateral olfactory tract–piriform cortex synapse; the selective mGluR8 agonist DCPG (300 nM) suppresses transmission, and the mGluR4 positive allosteric modulator PHCCC potentiates L-AP4 inhibition at this synapse.\",\n      \"method\": \"Whole-cell patch-clamp recordings in piriform cortex pyramidal cells, selective agonists and allosteric modulators\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patch-clamp with selective pharmacology, single lab\",\n      \"pmids\": [\"18625254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"mGluR8 mediates presynaptic depression of excitatory transmission in the bed nucleus of the stria terminalis (BNST): DCPG effects are absent in mGluR8 KO slices, associated with increased paired-pulse facilitation and decreased spontaneous EPSC frequency; this mGluR8-mediated suppression is disrupted by α1 adrenergic receptor activation and by both acute and chronic restraint stress in vivo, as well as in α2A AR KO mice.\",\n      \"method\": \"Electrophysiology in BNST slices from wild-type and mGlu8 KO mice, mGluR8 immunohistochemistry, pharmacological dissection with α1/α2 AR modulators, in vivo stress paradigms\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout, immunohistochemistry, and multiple pharmacological and stress manipulations in single study, multiple orthogonal methods\",\n      \"pmids\": [\"21451497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"mGluR8 achieves nearly complete inhibition of glutamate release at hippocampal lateral perforant path synapses without affecting presynaptic Ca2+ entry, diffusion, or buffering; instead, it acts by decreasing the apparent Ca2+ affinity of the release sensor and reducing maximal release rate. This action is resistant to inhibitors of adenylate cyclase and may represent a direct effect on the release machinery.\",\n      \"method\": \"Presynaptic Ca2+ imaging, miniature EPSC recording, quantitative Ca2+ dependence modeling, pharmacological blockade of adenylate cyclase and G-protein pathways\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (Ca2+ imaging, mEPSC, quantitative modeling, pharmacological dissection), mechanistically novel finding in single rigorous study\",\n      \"pmids\": [\"21903594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"mGlu8 but not mGlu7 ablation reduces contextual fear; mGlu8 agonist DCPG decreases synaptic transmission but not LTP at thalamo-lateral amygdala synapses, and intra-amygdala DCPG selectively reduces expression of contextual fear but not cued fear acquisition or expression, establishing distinct roles for mGlu7 and mGlu8 in amygdala synaptic physiology and fear behavior.\",\n      \"method\": \"Electrophysiology (LTP and synaptic transmission) in amygdala slices from mGlu7 and mGlu8 KO mice, intra-amygdala microinjection with behavioral fear testing\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic knockouts, in vitro electrophysiology, and in vivo behavioral experiments with pathway-level specificity\",\n      \"pmids\": [\"23664812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"mGluR8 negatively modulates TRPA1 activity on cutaneous nociceptors: DCPG (mGluR8 agonist) reduces TRPA1-mediated Ca2+ mobilization (co-localization of TRPA1 and mGluR8 confirmed), reverses mustard-oil-induced mechanical hypersensitivity in vivo, and reduces nociceptor firing at the single-fiber level; PKA inhibitor RpCAMPS mimics the DCPG effect, implicating the cAMP/PKA pathway.\",\n      \"method\": \"Ca2+ imaging in dorsal root ganglion neurons, in vivo paw withdrawal threshold testing, single-fiber electrophysiology, PKA inhibition\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (Ca2+ imaging, single-fiber recording, behavioral) in single lab, co-localization and functional coupling shown\",\n      \"pmids\": [\"27497709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The crystal structure of the human mGlu8 amino terminal domain (ATD) bound to L-AP4 and to L-glutamate was solved, revealing that L-glutamate binds differently in mGlu8 compared to mGlu1, and that both the electronic and steric properties of the distal phosphate of L-AP4 account for its group III selectivity.\",\n      \"method\": \"X-ray crystallography of recombinant human mGlu8 ATD\",\n      \"journal\": \"Bioorganic & medicinal chemistry letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional interpretation, single lab but direct structural determination\",\n      \"pmids\": [\"29402739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of recombinant human mGlu8 ATD bound to (S)-DCPG was solved; the structure shows the largest lobe opening angle among known agonist-bound mGlu ATD structures, and the DCPG binding conformation differs substantially from homology-model predictions, rationalizing (S)-DCPG's high mGlu8 subtype selectivity.\",\n      \"method\": \"X-ray crystallography, homology modeling of other mGlu subtypes\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct crystal structure with comparative structural analysis providing mechanistic basis for selectivity, single lab\",\n      \"pmids\": [\"30365309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GRM8 transcriptional activation in squamous cell lung cancer promotes tumor cell survival by inhibiting the cAMP pathway and activating the MAPK pathway; the SNV A112G identified in GRM8 activates downstream signaling and induces cell proliferation, reversed by cAMP stimulator and MEK inhibitor.\",\n      \"method\": \"CRISPR-Cas9 genome editing in patient-derived xenograft cells, cAMP and MAPK pathway assays, pharmacological rescue\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional genetic validation with CRISPR in primary tumor cells plus pharmacological pathway dissection, single lab\",\n      \"pmids\": [\"30391781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"mGluR8 downregulation in human neuroblastoma (SH-SY5Y) cells increases proliferation and chemoresistance (to staurosporine, doxorubicin, irinotecan, cisplatin) with decreased caspase, calpain, GSK-3β, Akt, and JNK activity; conversely, mGluR8 overexpression in glioma cells (U87-MG, LN18) decreases proliferation and increases apoptosis and chemosensitivity, identifying a tumor suppressor role.\",\n      \"method\": \"RNAi knockdown and cDNA overexpression, cell proliferation assays, caspase/calpain activity assays, kinase activity measurement\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional genetic manipulation (knockdown and overexpression) in multiple cell lines with multiple readouts, single lab\",\n      \"pmids\": [\"29885518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Selective activation of mGluR8 by DCPG reversibly reduces Off-light responses of retinal ganglion cells in wild-type but not mGluR8-deficient retinas by suppressing both excitatory and inhibitory synaptic conductances, indicating mGluR8 reduces glutamate release from bipolar cell terminals and possibly inhibitory transmitter release from amacrine cells.\",\n      \"method\": \"Extracellular and whole-cell light-evoked recording in wild-type and mGluR8 KO mouse retina\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout control, whole-cell conductance measurement, multiple cell types assessed\",\n      \"pmids\": [\"20096339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"mGlu8 receptor activation (DCPG) in the dentate gyrus inhibits LTP in normal rats but enhances impaired LTP in VPA-exposed (autism model) rats at the perforant path–dentate gyrus synapse; intra-DG DCPG also reverses reduced social novelty preference in VPA-exposed rats, suggesting mGlu8 dysfunction contributes to impaired synaptic plasticity in this ASD model.\",\n      \"method\": \"In vivo hippocampal field recording with high-frequency stimulation, intra-DG microinjection, social behavior testing in VPA rat model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo electrophysiology and behavioral assay with intra-site pharmacology, single lab\",\n      \"pmids\": [\"38849397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In the thalamic reticular nucleus (TRN), mGlu8 (grm8) mRNA is expressed in parvalbumin-positive cells of both TRN core and shell matrices and in cortical layers involved in corticothalamic signaling. Constitutive parvalbumin-specific mGlu8 knockout increases spontaneous excitatory drive onto dorsal thalamus relay cells and impairs sensorimotor gating (paired-pulse inhibition); TRN-conditional AAV-mediated grm8 knockdown produces hyperlocomotion and anxiolytic effects in repeated open field testing.\",\n      \"method\": \"Fluorescent in situ hybridization, conditional (AAV-CRE) and cell-type-specific constitutive knockout, whole-cell patch-clamp, paired-pulse inhibition, open field behavioral testing\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic strategies (constitutive cell-type KO + conditional viral KO), electrophysiology and behavior, cell-type resolution with FISH\",\n      \"pmids\": [\"38918065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DCPG at submicromolar concentrations selectively inhibits excitatory transmission in the lateral perforant path (LPP) via mGlu8; at concentrations >1 μM, DCPG produces additional non-selective effects in both LPP and medial perforant path (MPP) that are absent in mGlu8 KO but mediated primarily by mGlu2, as shown in mGlu2, mGlu4, and mGlu7 KO mice and an mGlu2-deficient rat substrain.\",\n      \"method\": \"Field EPSP recording in hippocampal slices from multiple receptor-specific knockout mice and a naturally mGlu2-deficient rat substrain\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic knockout models used to dissect receptor contributions, defines concentration-selectivity window for mGlu8\",\n      \"pmids\": [\"23220400\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GRM8 encodes a presynaptically localized group III metabotropic glutamate receptor that, upon agonist binding to its Venus flytrap module (VFTM closure required for activation), couples via pertussis-toxin-sensitive Gi/o proteins (Gβγ subunit signaling) to inhibit neurotransmitter release—not primarily by reducing Ca2+ entry but by decreasing the apparent Ca2+ affinity of the vesicle release sensor—at multiple CNS synapses including lateral perforant path–dentate gyrus, lateral olfactory tract–piriform cortex, retino-collicular, amygdalar, BNST, and thalamocortical synapses; in the TRN, mGlu8 in parvalbumin neurons restrains excitatory drive onto thalamic relay cells and supports sensorimotor gating, while peripherally it negatively modulates TRPA1 via the cAMP/PKA pathway; in cancer cells it acts as a tumor suppressor by inhibiting the cAMP pathway and modulating MAPK signaling, and its loss or gain-of-function produces anxiety, contextual fear, and sensorimotor gating phenotypes in rodents.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRM8 encodes mGlu8, a presynaptically localized group III metabotropic glutamate receptor that acts as an inhibitory autoreceptor restraining excitatory neurotransmitter release at defined CNS synapses [#0, #3]. Agonist binding requires closure of the receptor's Venus flytrap module: antagonists block activation by preventing lobe closure through ionic and steric hindrance, and mutating those contact residues converts antagonists into full agonists, establishing VFTM closure as the gating step for this family 3 GPCR [#2]; crystal structures of the human amino-terminal domain bound to L-AP4, L-glutamate, and the selective agonist DCPG rationalize group III and mGlu8-subtype selectivity [#16, #17]. The receptor couples through pertussis-toxin-sensitive Gi/o proteins via Gβγ signaling, and in heterologous systems activates GIRK currents [#1, #10]. At lateral perforant path–dentate gyrus terminals, mGlu8 produces near-complete inhibition of glutamate release without reducing presynaptic Ca2+ entry, instead lowering the apparent Ca2+ affinity of the release sensor and the maximal release rate in a manner resistant to adenylate cyclase inhibition—indicating a direct action on the release machinery [#13]. This presynaptic depression is selective and broadly distributed, demonstrated by knockout-confirmed, agonist-dependent suppression of transmission at lateral olfactory tract–piriform cortex, retino-collicular, retinal bipolar, amygdalar, and BNST synapses [#3, #5, #11, #12, #20, #23]. Functionally, mGlu8 modulates stress and fear circuitry: agonist activation engages GABAergic neurons in stress-related regions, attenuates amygdalar sensory transmission to inhibit conditioned and contextual fear, and its loss heightens anxiety, while in the thalamic reticular nucleus parvalbumin-neuron mGlu8 restrains excitatory drive onto relay cells and supports sensorimotor gating [#4, #6, #9, #14, #22]. Beyond the CNS, mGlu8 negatively modulates TRPA1 in cutaneous nociceptors via the cAMP/PKA pathway [#15], and in cancer cells it acts through cAMP and MAPK signaling with both tumor-suppressor and, via a gain-of-function variant, tumor-promoting effects [#18, #19].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established where mGlu8 acts by showing it resides in presynaptic axon terminals of projection neurons, defining it as a candidate release-modulating autoreceptor.\",\n      \"evidence\": \"Immunohistochemistry and electron microscopy combined with lateral olfactory tract transection in rhinencephalon\",\n      \"pmids\": [\"8710211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the downstream signaling or release-modulating function\", \"No physiological readout of receptor activity\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the receptor's pharmacology and effector coupling, showing two C-terminal splice variants with identical agonist profiles and coupling to GIRK channels.\",\n      \"evidence\": \"RT-PCR, heterologous expression in HEK293 with chimeric Gαqi9, and Xenopus oocyte electrophysiology with Kir3.1/3.4\",\n      \"pmids\": [\"9875342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of C-terminal splice variation unresolved\", \"Native G-protein coupling not identified in this heterologous system\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the molecular gating mechanism by showing Venus flytrap closure is required for activation, with specific residues controlling antagonist-versus-agonist behavior.\",\n      \"evidence\": \"Site-directed mutagenesis, molecular modeling, and functional assay in heterologous expression\",\n      \"pmids\": [\"12151600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how VFTM closure propagates to the transmembrane domain\", \"No structural confirmation at the time\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated native autoreceptor function with pathway selectivity, showing mGlu8 suppresses transmission specifically at lateral perforant path and retino-collicular synapses.\",\n      \"evidence\": \"Field EPSP recording in wild-type vs mGlu8 knockout slices with selective agonist DCPG and antagonist LY341495\",\n      \"pmids\": [\"12213276\", \"12213277\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of release suppression not yet defined\", \"Pathway selectivity basis unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked mGlu8 loss to anxiety behavior, connecting the receptor to emotional regulation in vivo.\",\n      \"evidence\": \"Behavioral phenotyping of independent mGlu8 knockout lines in the elevated plus maze\",\n      \"pmids\": [\"12213278\", \"12213279\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single behavioral readout per study\", \"Circuit responsible for the phenotype not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connected receptor activation to stress circuitry and showed engagement of GABAergic neurons, and that mGlu8 function is downregulated in epilepsy.\",\n      \"evidence\": \"c-Fos immunohistochemistry in wild-type vs knockout mice with GABAergic markers; concentration-response fEPSP recordings in a pilocarpine epilepsy model\",\n      \"pmids\": [\"12907308\", \"12539201\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal contribution of GABAergic engagement to behavior not established\", \"Mechanism of disease-associated downregulation unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved the G-protein effector mechanism in primary cells and showed differential transmitter regulation through a cAMP/PKA arm.\",\n      \"evidence\": \"Microspectrofluorimetry of Ca2+ in rod photoreceptors with PTX, CTX, Gβγ-inhibiting peptide and suramin; in vivo PAG microdialysis with PKA inhibitor H-89; amygdala patch-clamp with paired-pulse analysis\",\n      \"pmids\": [\"15623786\", \"16084932\", \"16188284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cAMP/PKA versus Ca2+-affinity mechanisms operate synapse-specifically not reconciled\", \"Identity of native coupling Gi isoform inferred, not proven\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the core presynaptic mechanism: near-complete release inhibition by lowering Ca2+ sensitivity of the release sensor rather than reducing Ca2+ entry, independent of adenylate cyclase.\",\n      \"evidence\": \"Presynaptic Ca2+ imaging, mEPSC recording, quantitative Ca2+-dependence modeling and pharmacological dissection at hippocampal LPP synapses\",\n      \"pmids\": [\"21903594\", \"21451497\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target on the release machinery not identified\", \"Reconciliation with cAMP/PKA-dependent effects elsewhere unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Distinguished mGlu8 from mGlu7 in amygdala physiology and fear, assigning mGlu8 a selective role in contextual fear expression.\",\n      \"evidence\": \"Electrophysiology and intra-amygdala microinjection with fear behavior in mGlu7 and mGlu8 knockout mice\",\n      \"pmids\": [\"23664812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Synaptic basis of contextual-versus-cued specificity not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extended mGlu8 function to peripheral nociception, showing negative modulation of TRPA1 via cAMP/PKA.\",\n      \"evidence\": \"DRG Ca2+ imaging, single-fiber recording, behavioral paw-withdrawal testing, and PKA inhibition\",\n      \"pmids\": [\"27497709\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct molecular link between PKA and TRPA1 not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided structural basis for ligand selectivity and revealed non-neuronal cancer roles through cAMP and MAPK signaling.\",\n      \"evidence\": \"X-ray crystallography of human ATD bound to L-AP4, L-glutamate, and DCPG; CRISPR and RNAi/overexpression in lung cancer, neuroblastoma and glioma cells with pathway rescue\",\n      \"pmids\": [\"29402739\", \"30365309\", \"30391781\", \"29885518\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Opposing tumor-suppressor and tumor-promoter findings not mechanistically reconciled\", \"Cancer signaling shown in single labs without in vivo confirmation\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Assigned mGlu8 a cell-type-specific role in thalamic circuit gating and in disease-model plasticity, linking it to sensorimotor gating and ASD-relevant deficits.\",\n      \"evidence\": \"FISH, parvalbumin-specific and AAV-conditional knockout with patch-clamp, paired-pulse inhibition and open-field behavior in TRN; in vivo DG field recording and social behavior in the VPA rat model\",\n      \"pmids\": [\"38918065\", \"38849397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Circuit mechanism translating TRN mGlu8 loss to gating deficits incomplete\", \"Whether VPA-model effects generalize to other ASD models unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular target on the vesicle release machinery through which mGlu8 lowers Ca2+-sensor affinity, and how this adenylate-cyclase-independent action coexists with cAMP/PKA-dependent effects in other tissues, remain unidentified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No defined effector at the release sensor\", \"Synapse- and tissue-specific switching between effector arms unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 1]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}